Literature DB >> 18162376

Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation.

W Weidner1, R U Anderson.   

Abstract

The evaluation of acute and chronic bacterial prostatitis and the diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection and inflammation is well defined. Men with symptoms of acute bacterial prostatitis (NIH I) have to undergo urine analysis and culture of the urine. An initial imaging of the prostate is suggested to exclude prostatic abscess. In chronic bacterial prostatitis (NIH II) the 4- and/or the 2-glass test for white blood cell counts and culture are necessary. Culture of semen has a lower sensitivity but is recommended for evaluation in selected men with problems with infertility. Imaging of the prostate is indicated to exclude abscess formations. In patients with chronic prostatitis/chronic pelvic pain syndrome (NIH III) symptom scoring is mandatory using the NIH-CPSI. The 4- and/or the 2-glass test are suggested to rule out bacterial infections. The routinely done analysis of urine and expressed prostatic secretions for leukocytes is debatable, especially due to the fact that the differentiation between patients with inflammatory and non-inflammatory subgroups of CP/CPPS may not be useful for the daily praxis. Optional investigations include the analysis for leukocytes in the ejaculate. Histopathological and molecular microbiological evaluation of prostatic tissue are investigational tests requiring for evaluation. Routine done serum PSA, routine imaging of the prostate and tests for Chlamydia trachomatis and Ureaplasma are not really proven to provide benefit for the patient. In patients with asymptomatic prostatitis (NIH IV) is no evaluation necessary unless considering antimicrobial therapy for elevated PSA or infertility.

Entities:  

Mesh:

Year:  2007        PMID: 18162376     DOI: 10.1016/j.ijantimicag.2007.07.044

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

Review 1.  Prostatitis and male pelvic pain syndrome: diagnosis and treatment.

Authors:  Florian M E Wagenlehner; Kurt G Naber; Thomas Bschleipfer; Elmar Brähler; Wolfgang Weidner
Journal:  Dtsch Arztebl Int       Date:  2009-03-13       Impact factor: 5.594

2.  Low-intensity extracorporeal shock wave therapy for III B chronic pelvic pain syndrome.

Authors:  Guizhong Li; Libo Man
Journal:  Transl Androl Urol       Date:  2020-06

3.  Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications.

Authors:  Vittorio Magri; Florian M E Wagenlehner; Emanuele Montanari; Emanuela Marras; Viviana Orlandi; Antonella Restelli; Erminio Torresani; Kurt G Naber; Gianpaolo Perletti
Journal:  Asian J Androl       Date:  2009-04-20       Impact factor: 3.285

4.  Chronic prostatitis: approaches for best management.

Authors:  Kyung Seop Lee; Jae Duck Choi
Journal:  Korean J Urol       Date:  2012-02-20

5.  Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline.

Authors:  Jon Rees; Mark Abrahams; Andrew Doble; Alison Cooper
Journal:  BJU Int       Date:  2015-06-16       Impact factor: 5.588

6.  Long term efficacy of extracorporeal shock wave therapy [ESWT] for treatment of refractory chronic abacterial prostatitis.

Authors:  Ghazi Mohammad Al Edwan; Muheilan Mustafa Muheilan; Omar Nabeeh M Atta
Journal:  Ann Med Surg (Lond)       Date:  2017-01-06

7.  Oral fosfomycin for the treatment of chronic bacterial prostatitis.

Authors:  Ilias Karaiskos; Lambrini Galani; Vissaria Sakka; Aikaterini Gkoufa; Odysseas Sopilidis; Dimitrios Chalikopoulos; Gerasimos Alivizatos; Eleni Giamarellou
Journal:  J Antimicrob Chemother       Date:  2019-05-01       Impact factor: 5.790

8.  The Semen Microbiome and Semen Parameters in Healthy Stallions.

Authors:  Carlota Quiñones-Pérez; Amparo Martínez; Isabel Ortiz; Francisco Crespo; José Luis Vega-Pla
Journal:  Animals (Basel)       Date:  2022-02-22       Impact factor: 2.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.